Is the use of RAS inhibitors safe in the current era of COVID-19 pandemic?

• Main Authors: Sungha Park (Author), Hae Young Lee (Author), Eun Joo Cho (Author), Ki Chul Sung (Author), Juhan Kim (Author), Dae-Hee Kim (Author), Sang-Hyun Ihm (Author), Kwang-il Kim (Author), Il-Suk Sohn (Author), Wook-Jin Chung (Author), Hyeon Chang Kim (Author), Sung Kee Ryu (Author), Wook Bum Pyun (Author), Jinho Shin (Author), on behalf of the Korean Society of Hypertension (Author)
• Format: Book
• Published: BMC, 2020-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Antihypertensive drugs are one of the most widely used pharmacologic agent in the world and it is predominantly used in the elderly subjects. Pneumonia is the most common cause of death in the extremely old subject. During infection and its complication such as sepsis, hypotension could be...